<h1>Workshop urges timely Alzheimer's recognition, validated diagnostics, caregiver support, and clinician duties to assess, communicate, mitigate misinformation</h1> A regional hospital, a patient-advocacy NGO and a diagnostics firm hosted a workshop addressing late recognition of Alzheimer's symptoms, caregiver burden and misinformation from mass social media. The session emphasized that delayed diagnosis-often due to misattribution of early cognitive signs-can limit therapeutic options and implicate clinical duties to diagnose promptly and document care. Organizers promoted use of validated diagnostics (e.g., CSF biomarkers) and nonpharmacologic interventions, and highlighted support groups for caregiver mental-health needs. The event underscores legal and ethical considerations for providers regarding timely assessment, accurate testing, clear communication, and mitigation of harm from misleading public information.